ASP-1645

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameASP-1645
Drug Alias NameP2Y12 receptor antagonist (Astellas Pharma)ASP-1645
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPurinergic receptor P2Y12 antagonistsCoagulation factor inhibitors
TargetsCoagulation factorPurinergic receptor P2Y12
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCardeusAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A